Barr Pharmaceuticals
| |
Industry | Pharmaceutical industry |
---|---|
Fate | Acquired by Teva Pharmaceutical Industries |
Founded | 1970 |
Defunct | December 23, 2008 |
Headquarters | Montvale, New Jersey |
Key people |
Bruce L. Downey, Chairman & CEO William T. McKee, CFO |
Products | Generic drugs |
Revenue |
|
| |
Total assets |
|
Total equity |
|
Number of employees | 8,900 (2007) |
Footnotes / references [1] |
Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries.
Approximately 75% of the company's revenues were from the sale of generic drugs, including 18% of sales which were from the sale of oral contraceptive pills.[1]
It was acquired by Teva Pharmaceutical Industries in 2008.[2]
History
Barr Laboratories Inc. was founded in New York in 1970 by Edwin A. Cohen.[3]
In 1993, Bruce L. Downey joined the company as its president and in 1994, he became chairman and chief executive officer of the company.[4]
In 1993, the company settled a patent infringement case and began distributing a generic version of tamoxifen citrate, a treatment for breast cancer.[5]
In 1995, the company received approval to manufacture and sell a generic version of zidovudine (AZT), a treatment for AIDS.[6]
In 1996, the company became the first to receive approval from the Food and Drug Administration to market generic Warfarin, which was previously only sold by DuPont.[7]
In 2001, the company acquired Duramed Pharmaceuticals for $589 million in stock.[8]
In August 2001, after a 5-year legal battle with Eli Lilly and Company, the company began selling a generic version of Prozac.[9]
In 2003, the company acquired Endeavor Pharmaceuticals for $35 million.[10]
In October 2006, the company acquired Pliva.[11]
On December 23, 2008, the company was acquired by Teva Pharmaceutical Industries and became part of Teva Active Pharmaceutical Ingredients (TAPI).[2]
References
- 1 2 "Barr Pharmaceuticals, Inc. 2007 Form 10-K Annual Report". U.S. Securities and Exchange Commission.
- 1 2 "TEVA COMPLETES ACQUISITION OF BARR" (Press release). Pliva. December 23, 2008.
- ↑ "Barr Pharmaceuticals, Inc. History". FundingUniverse. Retrieved June 25, 2018.
- ↑ "Former Barr CEO Downey joins NewSpring Capital". American City Business Journals. March 11, 2009.
- ↑ "PATENT SETTLEMENT LIFTS BARR LABORATORIES SHARES". The New York Times. March 9, 1993.
- ↑ "BARR LABORATORIES WINS F.D.A. APPROVAL FOR GENERIC AZT". The New York Times. February 28, 1995.
- ↑ FOSS, KRISTA (October 26, 2001). "BITTER PILL". The Globe and Mail.
- ↑ "Barr to Buy Duramed in a Stock Swap". Los Angeles Times. Reuters. June 30, 2001.
- ↑ PETERSEN, MELODY (August 2, 2001). "Drug Maker Is Set to Ship Generic Prozac". The New York Times.
- ↑ "COMPANY BRIEFS". The New York Times. December 4, 2003.
- ↑ "Barr Acquires PLIVA d.d." (Press release). Pliva. October 12, 2006.